Correlation Between PDS Biotechnology and Arcturus Therapeutics
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on PDS Biotechnology and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Arcturus Therapeutics.
Diversification Opportunities for PDS Biotechnology and Arcturus Therapeutics
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between PDS and Arcturus is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Arcturus Therapeutics go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Arcturus Therapeutics
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Arcturus Therapeutics. In addition to that, PDS Biotechnology is 1.1 times more volatile than Arcturus Therapeutics Holdings. It trades about -0.27 of its total potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about 0.04 per unit of volatility. If you would invest 1,800 in Arcturus Therapeutics Holdings on September 2, 2024 and sell it today you would earn a total of 34.00 from holding Arcturus Therapeutics Holdings or generate 1.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Arcturus Therapeutics Holdings
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Arcturus Therapeutics |
PDS Biotechnology and Arcturus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Arcturus Therapeutics
The main advantage of trading using opposite PDS Biotechnology and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Arcturus Therapeutics vs. 89bio Inc | Arcturus Therapeutics vs. Madrigal Pharmaceuticals | Arcturus Therapeutics vs. Pliant Therapeutics | Arcturus Therapeutics vs. Arcellx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |